2023 SXSW Conference Hosts Psychedelic Healthcare VC Fund Palo Santo
09. März 2023 10:19 ET
|
Palo Santo
CHICAGO and NEW YORK, March 09, 2023 (GLOBE NEWSWIRE) -- As therapeutic applications of psychedelics gain more traction in the mainstream consciousness, psychedelics are a major focus at SXSW 2023,...
Palo Santo Closes $50 Million Psychedelic Therapeutics Investment Fund
12. Oktober 2022 11:51 ET
|
Palo Santo
CHICAGO and NEW YORK, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Palo Santo, a venture capital fund focused on backing and building emerging psychedelic therapeutics companies, announced the closing of its...
Psychedelic Healthcare VC Fund Palo Santo to Participate as Panelists at SXSW Conference
24. Februar 2022 10:54 ET
|
Palo Santo
CHICAGO and NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Palo Santo, a leading psychedelic healthcare investment fund, will participate in two of the six panels devoted to psychedelic medicine in...
Psychedelic Healthcare VC Fund Palo Santo Appoints Zach Lomis as Partner
02. Februar 2022 08:00 ET
|
Palo Santo
CHICAGO and NEW YORK, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Palo Santo, a leading psychedelic healthcare investment fund, announced the appointment of Zach Lomis as partner. As part of Palo Santo’s...
U.S.-Based Psychedelic Healthcare VC Fund, Palo Santo, Appoints New Members to Its Advisory Board, Amid Rapid Growth in Psychedelic Sector
08. November 2021 08:37 ET
|
Palo Santo
CHICAGO, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Palo Santo, the leading U.S.–based psychedelic investment fund, announced its advisory board, which includes some of the world’s foremost leaders in their...
U.S.-Based Psychedelic Healthcare VC Fund, Palo Santo, Announces Recent Investment in neurocare Group
21. September 2021 08:51 ET
|
Palo Santo
CHICAGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Palo Santo, a U.S.-based psychedelic investment fund, announced its recent investment in neurocare Group AG (“neurocare”), a leading provider of...